Ingela Hallberg
Hoofd Techniek/Wetenschap/O&O bij Aptahem AB
Profiel
Ingela Hallberg is currently working as the Regional Medical Director at Otsuka Pharma Scandinavia AB, Director at Medcom-Advice AB, and Chief Medical Officer at Aptahem AB.
Previously, she worked as the Divisional Director-GPV & Pharmacovigilance at H.
Lundbeck A, Medical Director at H.
Lundbeck AB, Director at Emotra AB, Independent Director at BICO Group AB, and Vice President-Phase 1 Unit at IQVIA Clinical AB.
She obtained a doctorate degree from the University of Gothenburg in 1994.
Actieve functies van Ingela Hallberg
Bedrijven | Functie | Begin |
---|---|---|
Otsuka Pharma Scandinavia AB
Otsuka Pharma Scandinavia AB Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharma Scandinavia AB is a pharmaceutical and nutraceutical company based in Stockholm, SE. Otsuka Pharma Scandinavia aims to improve the health of patients by focusing on some of the world's unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. Otsuka Pharma Scandinavia is dedicated to making a difference for patients in their daily lives and focuses on getting the job done together as a team, guided by its values of integrity, compassion, excellence, creativity, and collaboration. The Swedish company is committed to conducting business ethically and in compliance with the laws and regulations of the countries where it operates. The company invests substantially in research and development in both common and rare conditions, with a network of 44 research institutes around the world. | Corporate Officer/Principal | 01-12-2017 |
Medcom-Advice AB | Directeur/Bestuurslid | - |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
Eerdere bekende functies van Ingela Hallberg
Bedrijven | Functie | Einde |
---|---|---|
BICO GROUP AB | Directeur/Bestuurslid | 26-04-2021 |
H. LUNDBECK A/S | Corporate Officer/Principal | 01-02-2013 |
IQVIA Clinical AB
IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | 01-08-2012 |
H. Lundbeck AB
H. Lundbeck AB Pharmaceuticals: MajorHealth Technology H. Lundbeck AB operates as a pharmaceutical company specializing in psychiatric and neurological disorders. It offers a broad range of products within brain diseases such as depression, schizophrenia, Alzheimer, and Parkinson. The company is headquartered in Malmo, Sweden. | Corporate Officer/Principal | 01-04-2010 |
EMOTRA AB (PUBL) | Directeur/Bestuurslid | - |
Opleiding van Ingela Hallberg
University of Gothenburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
H. LUNDBECK A/S | Health Technology |
Health Technology | |
BICO GROUP AB | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
IQVIA Clinical AB
IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Health Technology |
H. Lundbeck AB
H. Lundbeck AB Pharmaceuticals: MajorHealth Technology H. Lundbeck AB operates as a pharmaceutical company specializing in psychiatric and neurological disorders. It offers a broad range of products within brain diseases such as depression, schizophrenia, Alzheimer, and Parkinson. The company is headquartered in Malmo, Sweden. | Health Technology |
Emotra AB
Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
Otsuka Pharma Scandinavia AB
Otsuka Pharma Scandinavia AB Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharma Scandinavia AB is a pharmaceutical and nutraceutical company based in Stockholm, SE. Otsuka Pharma Scandinavia aims to improve the health of patients by focusing on some of the world's unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. Otsuka Pharma Scandinavia is dedicated to making a difference for patients in their daily lives and focuses on getting the job done together as a team, guided by its values of integrity, compassion, excellence, creativity, and collaboration. The Swedish company is committed to conducting business ethically and in compliance with the laws and regulations of the countries where it operates. The company invests substantially in research and development in both common and rare conditions, with a network of 44 research institutes around the world. | Health Technology |
Medcom-Advice AB |